Please or to access all these features

Weight loss chat

A space to talk openly about weight loss journeys and challenges. Mumsnet hasn't checked the qualifications of anyone posting here. You may wish to speak to a medical professional before starting any diet.

Is being Obese an illness?

803 replies

agel · 18/10/2026 16:15

Yes or No
Im really not trying to start an argument. I want to understand what people actually think/know/believe about this.

I am obese and am trying to gain some sort of control over my eating through therapy at the moment. I’ve tried diets and exercising that do work but long term I don’t seem to be able to change my lifestyle enough to keep the weight off. I hate living like this and how people treat me differently because of my size. My family don’t understand at all. My partner is not understanding and it’s seriously affecting our relationship in many ways. It seems unfair because I don’t feel I have much control over this. It’s actually very lonely being in this situation. I rarely mention the topic of my health or weight to others because pardon the pun it’s always the elephant in the room! But you can almost hear what people are thinking. I hate the judgemental looks and comments. I rarely go out now because of anxiety and panic attacks brought on by this situation.

OP posts:
Thread gallery
9
Ffiohna · 25/10/2026 13:35

@Charlenedickens
”….effort to remain in a cal defecit, to eat clean and healthy, to work out, strength train, drink enough water,
it isn’t like the drugs magically make you do these things or melt the fat off,….”

Of course I appreciate this. If you’ve never learned to cook, about nutrition, can meal plan, have enough money to buy the best food, for example, it will absolutely take effort to develop these tools and ways of eating. And to track a calorie deficit, once you know what that is for you.

But there are loads out there like me - I do all the things you list and more. I have always been able to cook, but understanding the calorie and nutrition densities was new. Yes that took some effort. As does putting every morcel into MFP. I didn’t have to knowingly monitor and control what I ate when I was pre peri. Though still ate well. Cooking is a life love!

Now the effort and battle every day is to eat what I do, in a deficit, or even out of deficit if I take a short break, with not feeling full. Admittedly this is just me but I absolutely KNOW that if WLI worked for me, the hardest thing I have to battle will ease. I will not have to sit with hunger (that probably isn’t even hunger). I would not have to make any effort to eat whole, quality, nutrition dense, food. To walk my dog. To weight train. To drink water. I’m doing these things now but I would hope that WLI would make me FEEL better and that my body is not telling me I am not nourishing it sufficiently.

I would need to make an effort to inject. Or with pills, not to forget to take them.

Maybe it wouldn’t be like this for me. I won’t know. But like everything else around the subject, I guess it’s complex and one person’s effort is another person’s normal. I’m not trying to diminish others’ efforts, I see my post could be read that way, so apologies if I have offended anyone 😔

Charlenedickens · 25/10/2026 13:49

Ffiohna · 25/10/2026 13:35

@Charlenedickens
”….effort to remain in a cal defecit, to eat clean and healthy, to work out, strength train, drink enough water,
it isn’t like the drugs magically make you do these things or melt the fat off,….”

Of course I appreciate this. If you’ve never learned to cook, about nutrition, can meal plan, have enough money to buy the best food, for example, it will absolutely take effort to develop these tools and ways of eating. And to track a calorie deficit, once you know what that is for you.

But there are loads out there like me - I do all the things you list and more. I have always been able to cook, but understanding the calorie and nutrition densities was new. Yes that took some effort. As does putting every morcel into MFP. I didn’t have to knowingly monitor and control what I ate when I was pre peri. Though still ate well. Cooking is a life love!

Now the effort and battle every day is to eat what I do, in a deficit, or even out of deficit if I take a short break, with not feeling full. Admittedly this is just me but I absolutely KNOW that if WLI worked for me, the hardest thing I have to battle will ease. I will not have to sit with hunger (that probably isn’t even hunger). I would not have to make any effort to eat whole, quality, nutrition dense, food. To walk my dog. To weight train. To drink water. I’m doing these things now but I would hope that WLI would make me FEEL better and that my body is not telling me I am not nourishing it sufficiently.

I would need to make an effort to inject. Or with pills, not to forget to take them.

Maybe it wouldn’t be like this for me. I won’t know. But like everything else around the subject, I guess it’s complex and one person’s effort is another person’s normal. I’m not trying to diminish others’ efforts, I see my post could be read that way, so apologies if I have offended anyone 😔

You certainly didn’t offend me, I was just explaining why some people say it takes effort, of course if you only eat healthy and work out, it’s just say a portion size issue, then it is no effort to change this, and yes it would ease if the onky issue you face is satiety,

so where as I had to correct before when I said it wasn’t without effort, just less effort, and had to correct that to it took effort to do it in a healthy manner, I will also correct to say if you’re someone who exclusively eats healthily and works out, drinks your water but has an issue with satiety, then in this instance also it will be barely any effort to none,

I was not saying , before anyone else gives me an example, that there is no situation it takes no effort, I was very clear I talked about the majority

for me also I ate healthy in the main and worked out, I did not drink enough water though, where my effort was I changed my diet , as healthy wasn’t good enough, I had to start understanding macros, prioritising protein, looking at the fats I cooked with, I stopped with fhings like butter and mayo, and I dished uo only a recommended portion and made myself stop when I finished it, and like most on the meds, I could have pushed through and eaten more.

i also had to uo my exercise, building more strength training in, and ensure I drank 3 litres of water a day.

I fully appreciate for some people that is no effort at all and I fully appreciate for some they just go on too high a dose and let the drugs do the work, as said I was clear I was talking about the majority, which you can see anecdotally all over social media, and not making a blanket wholesale statement on every individual who uses the meds to help them lose weight.

DeliaPith321 · 25/10/2026 15:08

My view is that the easier it is the better (to lose wight on GLP1s), so that the individual can become healthier and happier as efficiently as possible. The debates around effort I've mostly seen being based on moralistic factors from people who aren't aware of the biological or environmental influences that have caused the obesity epidemic in the first place. I'm not sure it's something that really matters.
I'd be interested to see if the GLP1s end up reducing the stigma around obesity or indeed whether that becomes worse. Especially as organisations as high level as the WHO have demonstrated concern over potential worsening health disparities caused by unequal access. There is also no convincing evidence that the GLP1s are going to ensure a reversal of population wide obesity. At the moment they are obviously relatively new and so people are excited but it may well be that we don't end up with the long term results that we envisaged. Further to that, the potential long term health effects - the same as vaping it is very much a time will tell situation.

Charlenedickens · 25/10/2026 15:29

DeliaPith321 · 25/10/2026 15:08

My view is that the easier it is the better (to lose wight on GLP1s), so that the individual can become healthier and happier as efficiently as possible. The debates around effort I've mostly seen being based on moralistic factors from people who aren't aware of the biological or environmental influences that have caused the obesity epidemic in the first place. I'm not sure it's something that really matters.
I'd be interested to see if the GLP1s end up reducing the stigma around obesity or indeed whether that becomes worse. Especially as organisations as high level as the WHO have demonstrated concern over potential worsening health disparities caused by unequal access. There is also no convincing evidence that the GLP1s are going to ensure a reversal of population wide obesity. At the moment they are obviously relatively new and so people are excited but it may well be that we don't end up with the long term results that we envisaged. Further to that, the potential long term health effects - the same as vaping it is very much a time will tell situation.

Hmmm, firstly the USA has already seen obesity rates start to reverse, for the first ever time in its history with a three percent drop already. so I’d be surprised if other countries don’t follow.

the hurdle is in the USA the meds are available on insurance,and due to salary levels fbe drugs are much cheaper on a direct purchase than in the uk in terms of salary percentage, so the USA has a higher uptake,hence seeing the drop,

im not going to engage on the long term effects nonsense, its nothing like vaping, this is a prescription medication that cost billions to bring to market, has been through the most strenuous testing , everything tightened up after thalidomide, and has nearly forty years of data, no drug is brought to market with hmm wonder what the long term effects are, I can assure you the scientists involved are fully capable of understanding the long term impacts, it is not left to chance,

vaping is a ludicrous comparison, but is still considered safer than smoking as originally touted, but carries irs own health issues, of course it does, it’s not like a prescription med and I’m stunned anyone would think to compare it.

DeliaPith321 · 25/10/2026 15:37

Charlenedickens · 25/10/2026 15:29

Hmmm, firstly the USA has already seen obesity rates start to reverse, for the first ever time in its history with a three percent drop already. so I’d be surprised if other countries don’t follow.

the hurdle is in the USA the meds are available on insurance,and due to salary levels fbe drugs are much cheaper on a direct purchase than in the uk in terms of salary percentage, so the USA has a higher uptake,hence seeing the drop,

im not going to engage on the long term effects nonsense, its nothing like vaping, this is a prescription medication that cost billions to bring to market, has been through the most strenuous testing , everything tightened up after thalidomide, and has nearly forty years of data, no drug is brought to market with hmm wonder what the long term effects are, I can assure you the scientists involved are fully capable of understanding the long term impacts, it is not left to chance,

vaping is a ludicrous comparison, but is still considered safer than smoking as originally touted, but carries irs own health issues, of course it does, it’s not like a prescription med and I’m stunned anyone would think to compare it.

We aren't the USA. The comparison with vaping was literally just to say that vaping is another fairly new thing we have to wait to see the effects of.

Before I engage any further I'd just like to say that these are all evidenced concerns that are the main topics of the current discourse academically and professionally. If you read back over my posts you will soon learn that evidence is what I will lead with. I'm actually more interested in hearing others views and research they may have done so your engagement is neither here or there.

I'm here to engage in respectful well-evidenced and balanced debate and conversation. Not mud slinging. I have said that before.

Charlenedickens · 25/10/2026 15:42

DeliaPith321 · 25/10/2026 15:37

We aren't the USA. The comparison with vaping was literally just to say that vaping is another fairly new thing we have to wait to see the effects of.

Before I engage any further I'd just like to say that these are all evidenced concerns that are the main topics of the current discourse academically and professionally. If you read back over my posts you will soon learn that evidence is what I will lead with. I'm actually more interested in hearing others views and research they may have done so your engagement is neither here or there.

I'm here to engage in respectful well-evidenced and balanced debate and conversation. Not mud slinging. I have said that before.

I’m sorry. But I stand by vaping is simply not comparable and the drugs are not new, they have been in use for over two decades with diabetics, the human body isn’t totally different if you’ve diabetes and they were in trials for 15 years before hand,

I am happy to look at peer reviewed scientific research that says the trials were a failure which didn’t address long term impacts on the human body and that the near in four decades of data is not enough, and as such approving prescription medication needs to be tightened up again globally if you link,

I am not happy to call it new drugs or compare to vaping,

Nottodaybob · 25/10/2026 16:08

Charlenedickens · 25/10/2026 11:39

Were you both eating a clean and healthy diet, ensuring the correct macros, working out several times a week to retain and protect muscle, drinking 2-3 litres a day of water, I think it is very rare anyone does that with no effort. Howver I get some people were obese who did that anyway so possibly see it as no effort,

I don't track macros - I don't think that's a healthy or natural way to live and it's not sustainable over 20-30years. We've always eaten well, low upf diet and lots of cooking from scratch, we've never had a "bad" diet, just far too much of it. We're generally very active anyway. And I pretty much only drink water so that wasn't something I needed to work on.

DeliaPith321 · 25/10/2026 16:57

Nottodaybob · 25/10/2026 16:08

I don't track macros - I don't think that's a healthy or natural way to live and it's not sustainable over 20-30years. We've always eaten well, low upf diet and lots of cooking from scratch, we've never had a "bad" diet, just far too much of it. We're generally very active anyway. And I pretty much only drink water so that wasn't something I needed to work on.

Definitely agree re macros.

DeliaPith321 · 25/10/2026 17:37

I think this could be helpful :)

How to recognise good-faith and bad-faith debating

Not everyone who disagrees with you is debating in bad faith. In fact, disagreement is often where the most interesting discussions begin. However, there are some useful signs that help distinguish a genuine exchange of ideas from an unproductive argument.

Signs of good-faith debating:

  • Intellectual curiosity: Asking questions to understand another person's reasoning, rather than simply looking for weaknesses to exploit.
  • Engaging with the actual argument: Responding to what someone has said, rather than misrepresenting their position.
  • Openness to evidence: Being willing to reconsider a position when presented with credible information.
  • Acknowledging valid points: Recognising when the other person makes a reasonable argument, even when you disagree overall.
  • Intellectual honesty: Admitting uncertainty, limitations in knowledge or mistakes.
  • Consistency: Applying the same standards of evidence and reasoning to your own arguments as you apply to others.
  • Separating ideas from identity: Challenging arguments without treating disagreement as a personal attack.

Signs of potentially bad-faith debating:

  • Strawman arguments: Distorting someone's position into something easier to attack.
  • Moving the goalposts: Continually changing what evidence would be sufficient once the original challenge has been met.
  • Ad hominem attacks: Attacking someone's character, intelligence or motives instead of addressing their argument.
  • Cherry-picking: Selecting only the evidence that supports a position while ignoring relevant contradictory evidence.
  • Whataboutism: Diverting attention to a different issue rather than addressing the point being discussed.
  • Sealioning: Repeatedly demanding explanations or evidence without meaningfully engaging with the answers already provided.
  • Mind-reading: Claiming to know another person's intentions, emotions or motivations without sufficient evidence.
  • Deliberate misinterpretation: Persistently adopting the least charitable interpretation of someone's words despite clarification.
  • Personalising disagreement: Shifting the discussion away from the subject and towards perceived insults, tone or interpersonal grievances.

An important distinction: These behaviours do not automatically prove bad faith. People can misunderstand arguments, become defensive or use poor reasoning without deliberately attempting to derail a discussion. Bad faith concerns intention, which is not always possible to establish from behaviour alone.
For me, the purpose of debate is not necessarily to reach agreement. It is to examine ideas, challenge assumptions, test evidence and perhaps leave with a more sophisticated understanding than we started with.
A productive debate doesn't require agreement, emotional validation or even liking the person you're debating. It requires intellectual honesty, curiosity and a willingness to engage with the argument actually being made.
Disagreement is not disrespect. Being challenged is not the same as being attacked. And changing your mind in response to better evidence is not losing a debate — it's intellectual progress.

Charlenedickens · 25/10/2026 18:10

Well since we are using rhe thread as a teaching opportunity this too can be helpful :-)

difference between debate and discussion

The main difference is that a discussion aims to explore ideas and build mutual understanding, while a debate aims to win an argument and persuade an audience.
Discussion

  • Goal: To learn, share perspectives, investigate a topic together, and reach shared insight or consensus.
  • Mindset: Participants stay open to new information and are willing to change their views.
  • Format: Informal, fluid, cooperative, and open-ended.
  • Structure: People talk with each other rather than against each other, and listening focuses on understanding meaning.
Debate
  • Goal: To prove the superiority of a specific stance and defeat an opposing position.
  • Mindset: Participants defend a fixed side and listen closely to find flaws, errors, or weaknesses in the other side's arguments.
  • Format: Formal, structured, and governed by strict rules (such as timed speeches and rebuttals).

anyone else want to treat the readers like they need help?

DeliaPith321 · 25/10/2026 18:38

MargoLivebetter · 23/10/2026 11:08

@ExpectMore and again the irony:

"Perhaps we need to include basics of debating on the national curriculum alongside healthy eating (or if it’s already there, understand why Charlenedickens skipped those modules)." You endlessly illustrate your own points so very well.

You are of course entirely free to judge away as much as you like, but it seems contradictory to make such judgements and name call yourself but not want others to do so. I believe it is perfectly possible to engage in debate without name calling.

There isn't much moderation (unless people report) and I think the good / bad faith info can be useful. I wasn't even aware of the terms in debate until a couple of years ago and wouldn't necessarily assume everyone else has either. I especially think it can be useful on a thread like this where people are far more likely to be in their feelings.

DeliaPith321 · 25/10/2026 20:45

GLP-1 weight-loss injections: What do we actually know about the long-term risks, what happens when people stop, and the implications for the UK?
There is considerable enthusiasm about medications such as Wegovy (semaglutide) and Mounjaro (tirzepatide), and understandably so. Clinical trials have demonstrated substantial weight loss and, in some patient groups, significant improvements in cardiovascular and metabolic health.
However, I think it's important that discussions include the limitations of the evidence, particularly when these medications may need to be taken for many years.
1. We still don't know the consequences of taking newer GLP-1 treatments for decades.
Although GLP-1 medications have been used to treat diabetes for approximately 20 years, the newer obesity treatments, higher doses and widespread use in different populations are relatively recent.
We have encouraging evidence extending approximately three to four years for some treatments, but not the 10-, 20- or 30-year evidence that would help establish the consequences of lifelong treatment.
Established or recognised risks include:

  • Gastrointestinal problems, including nausea, vomiting, constipation and diarrhoea. Severe cases can lead to dehydration and hospitalisation.
  • Gallbladder problems, including gallstones.
  • Acute pancreatitis, which is uncommon but can be severe.
  • Loss of lean body mass alongside fat during weight reduction, raising questions about muscle preservation and longer-term physical function.
  • Potential nutritional inadequacy when appetite suppression results in insufficient dietary intake.
  • A very rare but serious eye condition, NAION, associated specifically with semaglutide, which can cause sudden visual loss.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has strengthened warnings about pancreatitis, including rare reports of fatal cases. Importantly, none of this means these medications are generally unsafe. It means the benefits and risks must be assessed for the individual, and some long-term questions remain unresolved. 2. What happens when people stop taking them? This is perhaps one of the most important findings from the research. A systematic review and meta-analysis published in the BMJ in 2026 examined weight regain following discontinuation of weight-management medications. For newer treatments, including semaglutide and tirzepatide, researchers estimated average weight regain of approximately 0.8 kg per month after stopping. They projected that participants could return to their original weight approximately 1.5 years after discontinuation. This was a statistical projection, not a finding that everyone had regained all their weight after 18 months. The available follow-up evidence was limited. Nevertheless, the findings are consistent with randomised withdrawal trials demonstrating substantial weight regain after treatment ends. This raises an obvious question: if weight maintenance frequently requires ongoing medication, how will long-term treatment be funded, particularly for people who cannot afford private prescriptions indefinitely? 3. The World Health Organization has raised concerns about health inequalities. In its 2025 guidance, the WHO conditionally recommended long-term GLP-1 treatment for adults living with obesity. The recommendation was conditional partly because of limited long-term evidence, high costs, health-system capacity and concerns about equitable access. The WHO warned that high prices, limited manufacturing capacity and unequal access could create a situation in which people with greater financial resources receive effective treatment while others are excluded. This is particularly concerning because obesity is strongly associated with socioeconomic deprivation. We therefore risk a situation in which people experiencing some of the greatest obesity-related health burdens have the least access to newer treatments. The WHO also emphasised that medication alone cannot solve the obesity epidemic. Wider action addressing food environments, socioeconomic conditions and the commercial determinants of health remains necessary. 4. Why the UK cannot simply be compared with the United States I frequently see arguments based on American prescribing patterns, insurance arrangements, drug prices and expectations about future availability. But the UK operates within a fundamentally different healthcare and medicines-funding system. In England, NHS access to obesity medications is governed by NICE recommendations, clinical eligibility criteria, NHS commissioning arrangements and available resources. For example, Mounjaro is being introduced through a phased NHS rollout, prioritising patients with the greatest clinical need. Wider eligibility does not mean immediate access for everyone who meets the eventual criteria. In the US, access is heavily influenced by private insurance arrangements, employer coverage, public insurance programmes and individual ability to pay. These are different systems with different mechanisms for determining who receives treatment and who pays. Even if generic or cheaper alternatives become available, lower manufacturing costs do not automatically translate into immediate, unrestricted NHS prescribing. NICE must consider clinical effectiveness and cost-effectiveness, while the NHS must fund the medication, provide appropriate monitoring and manage demand alongside other healthcare priorities. We also need to remember that healthcare arrangements differ across the UK's four nations. 5. The bigger question I don't think this debate needs to become a choice between celebrating GLP-1 medications or dismissing them. They represent a significant development in obesity treatment, and the evidence for their effectiveness is substantial. But effectiveness, long-term safety, affordability, sustainability and equitable access are different questions. If large numbers of people need treatment for many years to maintain weight loss, that has major implications for patients, public finances and the organisation of healthcare. And if access is determined increasingly by the ability to pay, we could see existing health inequalities widen. These are legitimate public-health concerns, not arguments against people using medication. The challenge is to make sure enthusiasm about an effective treatment doesn't get ahead of the evidence or distract from the wider conditions contributing to obesity in the first place.

Sources

  1. World Health Organization (2025), WHO Guideline on GLP-1 Therapies for Obesity in Adults, JAMA. https://doi.org/10.1001/jama.2025.24288
  2. BMJ (2026), Weight regain after cessation of medication for weight management: systematic review and meta-analysis. https://www.bmj.com/content/392/bmj-2025-085304
  3. MHRA, GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis. https://www.gov.uk/drug-safety-update/glp-1-receptor-agonists-and-dual-glp-1-slash-gip-receptor-agonists-strengthened-warnings-on-acute-pancreatitis-including-necrotising-and-fatal-cases
  4. MHRA, Semaglutide: risk of non-arteritic anterior ischaemic optic neuropathy (NAION). https://www.gov.uk/drug-safety-update/semaglutide-wegovy-ozempic-and-rybelsus-risk-of-non-arteritic-anterior-ischemic-optic-neuropathy-naion
  5. NICE, Tirzepatide for managing overweight and obesity, Technology Appraisal TA1026. https://www.nice.org.uk/guidance/ta1026

Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioration in vision, usually in one eye at a time, has been very rarely reported in association with semaglutide in the treatment of type 2 diabetes, weight...

https://www.gov.uk/drug-safety-update/semaglutide-wegovy-ozempic-and-rybelsus-risk-of-non-arteritic-anterior-ischemic-optic-neuropathy-naion

Charlenedickens · 25/10/2026 21:10

DeliaPith321 · 25/10/2026 20:45

GLP-1 weight-loss injections: What do we actually know about the long-term risks, what happens when people stop, and the implications for the UK?
There is considerable enthusiasm about medications such as Wegovy (semaglutide) and Mounjaro (tirzepatide), and understandably so. Clinical trials have demonstrated substantial weight loss and, in some patient groups, significant improvements in cardiovascular and metabolic health.
However, I think it's important that discussions include the limitations of the evidence, particularly when these medications may need to be taken for many years.
1. We still don't know the consequences of taking newer GLP-1 treatments for decades.
Although GLP-1 medications have been used to treat diabetes for approximately 20 years, the newer obesity treatments, higher doses and widespread use in different populations are relatively recent.
We have encouraging evidence extending approximately three to four years for some treatments, but not the 10-, 20- or 30-year evidence that would help establish the consequences of lifelong treatment.
Established or recognised risks include:

  • Gastrointestinal problems, including nausea, vomiting, constipation and diarrhoea. Severe cases can lead to dehydration and hospitalisation.
  • Gallbladder problems, including gallstones.
  • Acute pancreatitis, which is uncommon but can be severe.
  • Loss of lean body mass alongside fat during weight reduction, raising questions about muscle preservation and longer-term physical function.
  • Potential nutritional inadequacy when appetite suppression results in insufficient dietary intake.
  • A very rare but serious eye condition, NAION, associated specifically with semaglutide, which can cause sudden visual loss.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has strengthened warnings about pancreatitis, including rare reports of fatal cases. Importantly, none of this means these medications are generally unsafe. It means the benefits and risks must be assessed for the individual, and some long-term questions remain unresolved. 2. What happens when people stop taking them? This is perhaps one of the most important findings from the research. A systematic review and meta-analysis published in the BMJ in 2026 examined weight regain following discontinuation of weight-management medications. For newer treatments, including semaglutide and tirzepatide, researchers estimated average weight regain of approximately 0.8 kg per month after stopping. They projected that participants could return to their original weight approximately 1.5 years after discontinuation. This was a statistical projection, not a finding that everyone had regained all their weight after 18 months. The available follow-up evidence was limited. Nevertheless, the findings are consistent with randomised withdrawal trials demonstrating substantial weight regain after treatment ends. This raises an obvious question: if weight maintenance frequently requires ongoing medication, how will long-term treatment be funded, particularly for people who cannot afford private prescriptions indefinitely? 3. The World Health Organization has raised concerns about health inequalities. In its 2025 guidance, the WHO conditionally recommended long-term GLP-1 treatment for adults living with obesity. The recommendation was conditional partly because of limited long-term evidence, high costs, health-system capacity and concerns about equitable access. The WHO warned that high prices, limited manufacturing capacity and unequal access could create a situation in which people with greater financial resources receive effective treatment while others are excluded. This is particularly concerning because obesity is strongly associated with socioeconomic deprivation. We therefore risk a situation in which people experiencing some of the greatest obesity-related health burdens have the least access to newer treatments. The WHO also emphasised that medication alone cannot solve the obesity epidemic. Wider action addressing food environments, socioeconomic conditions and the commercial determinants of health remains necessary. 4. Why the UK cannot simply be compared with the United States I frequently see arguments based on American prescribing patterns, insurance arrangements, drug prices and expectations about future availability. But the UK operates within a fundamentally different healthcare and medicines-funding system. In England, NHS access to obesity medications is governed by NICE recommendations, clinical eligibility criteria, NHS commissioning arrangements and available resources. For example, Mounjaro is being introduced through a phased NHS rollout, prioritising patients with the greatest clinical need. Wider eligibility does not mean immediate access for everyone who meets the eventual criteria. In the US, access is heavily influenced by private insurance arrangements, employer coverage, public insurance programmes and individual ability to pay. These are different systems with different mechanisms for determining who receives treatment and who pays. Even if generic or cheaper alternatives become available, lower manufacturing costs do not automatically translate into immediate, unrestricted NHS prescribing. NICE must consider clinical effectiveness and cost-effectiveness, while the NHS must fund the medication, provide appropriate monitoring and manage demand alongside other healthcare priorities. We also need to remember that healthcare arrangements differ across the UK's four nations. 5. The bigger question I don't think this debate needs to become a choice between celebrating GLP-1 medications or dismissing them. They represent a significant development in obesity treatment, and the evidence for their effectiveness is substantial. But effectiveness, long-term safety, affordability, sustainability and equitable access are different questions. If large numbers of people need treatment for many years to maintain weight loss, that has major implications for patients, public finances and the organisation of healthcare. And if access is determined increasingly by the ability to pay, we could see existing health inequalities widen. These are legitimate public-health concerns, not arguments against people using medication. The challenge is to make sure enthusiasm about an effective treatment doesn't get ahead of the evidence or distract from the wider conditions contributing to obesity in the first place.

Sources

  1. World Health Organization (2025), WHO Guideline on GLP-1 Therapies for Obesity in Adults, JAMA. https://doi.org/10.1001/jama.2025.24288
  2. BMJ (2026), Weight regain after cessation of medication for weight management: systematic review and meta-analysis. https://www.bmj.com/content/392/bmj-2025-085304
  3. MHRA, GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis. https://www.gov.uk/drug-safety-update/glp-1-receptor-agonists-and-dual-glp-1-slash-gip-receptor-agonists-strengthened-warnings-on-acute-pancreatitis-including-necrotising-and-fatal-cases
  4. MHRA, Semaglutide: risk of non-arteritic anterior ischaemic optic neuropathy (NAION). https://www.gov.uk/drug-safety-update/semaglutide-wegovy-ozempic-and-rybelsus-risk-of-non-arteritic-anterior-ischemic-optic-neuropathy-naion
  5. NICE, Tirzepatide for managing overweight and obesity, Technology Appraisal TA1026. https://www.nice.org.uk/guidance/ta1026

Honestly you’re better looking at scientific data than outdated stuff published by rhe government, lots and lots of data out there, showing long term usage and rhe benefits, of course there are patients on for decades and of course each iteration is not a brand new medicine, but an advancement of previous ones, a bit like how they could create the Covid vaccine so easily.

https://www.sciencedirect.com/science/article/pii/S0146280625002324

however genuinely i think its worth pointing out, everyone has their own risk assessment, taking the medication is a choice, no one is forced and if needs to be weighed up against the known risks of obesity, the fact it is the number one killer in society, the leading cause of cancer in non smokers, the second in smokers, and that’s before we look at heart attack stroke, fatty liver, kidney disease, gall stones, pancreatitits etc obesity causes, these are not unknown, they are factual,

I know what I will take, the scientific findings on the health benefits of long term use or the absolute life ending or life limiting impact of obesity.

DeliaPith321 · 25/10/2026 21:19

Charlenedickens · 25/10/2026 21:10

Honestly you’re better looking at scientific data than outdated stuff published by rhe government, lots and lots of data out there, showing long term usage and rhe benefits, of course there are patients on for decades and of course each iteration is not a brand new medicine, but an advancement of previous ones, a bit like how they could create the Covid vaccine so easily.

https://www.sciencedirect.com/science/article/pii/S0146280625002324

however genuinely i think its worth pointing out, everyone has their own risk assessment, taking the medication is a choice, no one is forced and if needs to be weighed up against the known risks of obesity, the fact it is the number one killer in society, the leading cause of cancer in non smokers, the second in smokers, and that’s before we look at heart attack stroke, fatty liver, kidney disease, gall stones, pancreatitits etc obesity causes, these are not unknown, they are factual,

I know what I will take, the scientific findings on the health benefits of long term use or the absolute life ending or life limiting impact of obesity.

I'm a first class masters student. So with all due respect I'm confident about my sources and won't be taking advice from someone who called my ideas 'ludicrous nonsense' for no valid reason. I'm tired of the 'of course' and low-effort point towards individual differences. This message board won't allow me to block people so can I ask that you kindly do not further try to engage with my posts because you're wasting my time. I would prefer to converse with people who know how to engage in intellectual debate or no one at all. I don't give a shit about your personal life choices. I'm trying to get this discussion going again with some good quality data on the main debates.

Charlenedickens · 25/10/2026 21:28

DeliaPith321 · 25/10/2026 21:19

I'm a first class masters student. So with all due respect I'm confident about my sources and won't be taking advice from someone who called my ideas 'ludicrous nonsense' for no valid reason. I'm tired of the 'of course' and low-effort point towards individual differences. This message board won't allow me to block people so can I ask that you kindly do not further try to engage with my posts because you're wasting my time. I would prefer to converse with people who know how to engage in intellectual debate or no one at all. I don't give a shit about your personal life choices. I'm trying to get this discussion going again with some good quality data on the main debates.

Edited

So am I and you still posted outdated stuff from the government,

DeliaPith321 · 25/10/2026 21:31

Charlenedickens · 25/10/2026 21:28

So am I and you still posted outdated stuff from the government,

😂😂As if.

DeliaPith321 · 25/10/2026 21:49

Just to clarify - I was laughing because I thought you were saying 'so am I' to the first class masters part of my post. But whether this is your version of trying to continue an intellectual debate or not I am looking forward to other people posting again otherwise I'm going to split and find some proper conversation elsewhere.

rememberingthem · 25/10/2026 21:50

Its a mental illness/ addiction. Anyone who is stupid enough to believe that obese people end up that way purely because they are greedy and lazy is an imbecile imo.

Charlenedickens · 25/10/2026 21:54

DeliaPith321 · 25/10/2026 21:49

Just to clarify - I was laughing because I thought you were saying 'so am I' to the first class masters part of my post. But whether this is your version of trying to continue an intellectual debate or not I am looking forward to other people posting again otherwise I'm going to split and find some proper conversation elsewhere.

Yes I was saying that.

you are not coming across now with any form of credibility. And I won’t respond to you any further.

MyDarlingWhatIfYouFly · 25/10/2026 21:59

It’s an eating disorder - since I started wegovy i now know how “normal” people feel. Before taking it I thought about food pretty constantly, it was uncontrollable. Now it’s like part of my brain has switched off, I still enjoy eating food, but it doesn’t occupy every waking moment like it used to.

CoconutSwirl · 25/10/2026 22:06

I didn't know GLP-1 needs to be taken for life, like statins or antihypertensives.
So I took a loan out for £2,000 and told myself to use MJ until that money was used up, then stop. My rationale being that I couldn't afford to borrow any more than this, so however much weight I lost in £2,000 worth of doses, that would be that.
After 20 years of WW, SW, Atkinson, Cambridge, 5/2, fasting, and nothing ever working, I was prepared to pay money for weight loss.
So my £2,000 lasted 6 months.
In that time, I lost 4 stone.
I reached a BMI 26.
It revolutionised my life. I wept with relief. My energy levels soared. My clothes from 20 years ago fit me again. I started exercising at classes because my body no longer hurt all over and I began swimming because I felt ok about being seen in public in a swimsuit. Photos of myself suddenly looked nice. I felt alive again. All of this fed into my self esteem and boosted in tenfold.
I stopped taking them after I hit £2,000.
My loan had run out.
Within 4 months I gained back 2 stone.
I now can't get that 2 stone back off again. I've been trying for months, since April.
My point is, I never knew it was a drug for life.
It only works if you're on it.
Simple as that.

ExpectMore · 25/10/2026 22:13

ScaramoucheCanYouDoTheFandango · 25/10/2026 13:21

There isn't universal agreement on whether obesity is an illness, disease or condition, but some major health organisations now classify obesity as a chronic disease or chronic health condition rather than simply a lifestyle choice.

Many argue obesity must either be a disease or a matter of personal choice.

My own take is probably both can be true. Our biology influences our response to the current food and work/life environment we live in, and in it our biology influences our appetite, satiety, metabolism and susceptibility to weight gain, but behaviour still matters too. GLP1 help with the former allowing patients work on the later.

After 30+ years of obesity and yoyo dieting I would not have been able to go from morbidly obese to a normal BMI without the support of GLP1s. I believe now I have been obesity, or "have obesity" it is a condition I will need to manage carefully for the rest of my (hopefully longer and higher quality) life.

It is still a concern to me, for my dc and young family members, who are currently not obese but may be in the future, that we are medicalising a broader societal problem we have in UK and many other western countries and we need to address the environmental and other factors that contribute to rising obesity rates.

Edited

That’s a really nice way to describe my concern re. the use of these drugs that I’ve not occurred to articulate in that way before: the medicalisation of a problem that in reality, is one of our own creation and thus can be one of our own solving without the need for meds through healthy eating and activity.

It’s frightening we’ve created medicines because we’ve created a system in which people can’t stop over consuming and not moving enough.

it’s very dystopian in nature.

OrangeBlaze · 25/10/2026 23:01

ExpectMore · 25/10/2026 22:13

That’s a really nice way to describe my concern re. the use of these drugs that I’ve not occurred to articulate in that way before: the medicalisation of a problem that in reality, is one of our own creation and thus can be one of our own solving without the need for meds through healthy eating and activity.

It’s frightening we’ve created medicines because we’ve created a system in which people can’t stop over consuming and not moving enough.

it’s very dystopian in nature.

The dystopian part was your suggestion of denying healthcare to fat people. That's a genuinely monstrous idea, to force medics to let patients suffer, be in pain, maybe even die because you've decided it's their fault and is something we would only see in a dystopia.

'Medicalising' obesity though? Well, it's a medical condition. Caused as has been explained ad nauseum by a complex interplay of factors social, behavioural and biological. The latter requiring medication.

There is no turning back the clock on the modern world. And if you don't agree with the government having influence on people's lives (in a positive way - like regulating food corporations, increasing green spaces etc which apparently you don't like though as said previously removing access to healthcare for those deemed undeserving is fine by you!) then there really is no way to mitigate the obesogenic elements of the environment. It's not a problem 'of our own solving' when the only solution you will countenance is people just managing to not be fat - because that patently isn't happening and isn't going to happen. People have been getting fatter in a sharp increase all across the world over the past few decades and the only thing having an impact on that is the breakthrough of GLP-1s. That is how the problem is actually getting solved - no one has come up with another solution that works in reality.

Charlenedickens · 26/10/2026 06:11

CoconutSwirl · 25/10/2026 22:06

I didn't know GLP-1 needs to be taken for life, like statins or antihypertensives.
So I took a loan out for £2,000 and told myself to use MJ until that money was used up, then stop. My rationale being that I couldn't afford to borrow any more than this, so however much weight I lost in £2,000 worth of doses, that would be that.
After 20 years of WW, SW, Atkinson, Cambridge, 5/2, fasting, and nothing ever working, I was prepared to pay money for weight loss.
So my £2,000 lasted 6 months.
In that time, I lost 4 stone.
I reached a BMI 26.
It revolutionised my life. I wept with relief. My energy levels soared. My clothes from 20 years ago fit me again. I started exercising at classes because my body no longer hurt all over and I began swimming because I felt ok about being seen in public in a swimsuit. Photos of myself suddenly looked nice. I felt alive again. All of this fed into my self esteem and boosted in tenfold.
I stopped taking them after I hit £2,000.
My loan had run out.
Within 4 months I gained back 2 stone.
I now can't get that 2 stone back off again. I've been trying for months, since April.
My point is, I never knew it was a drug for life.
It only works if you're on it.
Simple as that.

It’s a drug for life for some, not for others, there are many options,

stay on a low dose for life
come off and maintain your new eating habits and exercise plan and buy the occassional pen if you gain a few pounds to get you back on track, most suppliers let you restart within a year and you don’t need to be overweight again,
stay off for good and maintain your eating habits,

of course the drugs don’t work if you don’t take them, no drug exists that works if you don’t take it,

I don’t understand how you spent 2 k in six months though, that’s not possible, by month six you’d only be hitting the top dose assuming you rushed up the doses to 15mg, whi did you buy from?

CoconutSwirl · 26/10/2026 07:10

This reply has been deleted

Message deleted by MNHQ. Here's a link to our Talk Guidelines.

Swipe left for the next trending thread